ロード中...
PD-1 and PD-L1 are more highly expressed in high-grade bladder cancer than in low-grade cases: PD-L1 might function as a mediator of stage progression in bladder cancer
Abstract Background Bladder cancers have been characterized as a tumor group in which the immunological response is relatively well preserved. Programmed death ligand 1 (PD-L1, B7-H1, CD274) has been shown to be expressed in several malignancies, including bladder cancer. However, the clinicopatholo...
保存先:
主要な著者: | , , , , , , , , , , , , , , , , , , |
---|---|
フォーマット: | Artigo |
言語: | Inglês |
出版事項: |
BMC
2018-11-01
|
シリーズ: | BMC Urology |
主題: | |
オンライン・アクセス: | http://link.springer.com/article/10.1186/s12894-018-0414-8 |
タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|